Heterogeneity of KRAS Mutation Status in Rectal Cancer.

Anti-EGFR targeted therapy is of increasing importance in advanced colorectal cancer and prior KRAS mutation testing is mandatory for therapy. However, at which occasions this should be performed is still under debate. We aimed to assess in patients with locally advanced rectal cancer whether there...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Peter Jo, Alexander König, Markus Schirmer, Julia Kitz, Lena-Christin Conradi, Azadeh Azizian, Markus Bernhardt, Hendrik A Wolff, Marian Grade, Michael Ghadimi, Philipp Ströbel, Hans-Ulrich Schildhaus, Jochen Gaedcke
Format:	Artigo
Sprog:	Inglês
Udgivet:	Public Library of Science (PLoS) 2016-01-01
Serier:	PLoS ONE
Online adgang:	http://europepmc.org/articles/PMC4827807?pdf=render
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!